Ultragenyx
IPOUnited States · $120.0M raised
- Headquarters
- California
- Business Model
- B2B
- Total Funding
- $120.0M
- Last Round
- $75.0M Series BDec 2012
- Rounds
- 2
About
Ultragenyx is a biopharmaceutical company focused on developing treatments for rare and ultrarare genetic diseases.
Summary
Ultragenyx is a Biotech company based in United States. It has raised $120.0M in total across 2 rounds, most recently a $75.0M Series B round in Dec 2012. Investors include TPG Biotech, Fidelity Biosciences and Adage Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2014
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company